Prenatal diagnosis of a distal 3p deletion associated with fetoplacental chromosomal discrepancy and confined placental mosaicism detected by array comparative genomic hybridization  by Chen, Chih-Ping et al.
Available online at www.sciencedirect.comTaiwanese Journal of Obstetrics & Gynecology 52 (2013) 278e284
www.tjog-online.comCase Report
Prenatal diagnosis of a distal 3p deletion associated with fetoplacental
chromosomal discrepancy and confined placental mosaicism detected by
array comparative genomic hybridization
Chih-Ping Chen a,b,c,d,e,f,g,*, Yi-Yung Chen a, Schu-Rern Chern b, Peih-Shan Wu h, Jun-Wei Su a,i,
Wen-Lin Chen a, Wayseen Wang b,j
aDepartment of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan
bDepartment of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan
cDepartment of Medicine, Mackay Medical College, New Taipei City, Taiwan
dDepartment of Biotechnology, Asia University, Taichung, Taiwan
e School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan
f Institute of Clinical and Community Health Nursing, National Yang-Ming University, Taipei, Taiwan
gDepartment of Obstetrics and Gynecology, School of Medicine, National Yang-Ming University, Taipei, Taiwan
hGene Biodesign Co. Ltd, Taipei, Taiwan
iDepartment of Obstetrics and Gynecology, China Medical University Hospital, Taichung, Taiwan
jDepartment of Bioengineering, Tatung University, Taipei, Taiwan
Accepted 28 March 2013AbstractObjective: This study is aimed at prenatal diagnosis of a distal 3p deletion associated with fetoplacental chromosomal discrepancy and confined
placental mosaicism, and providing evidence for the limitation of array comparative genomic hybridization (aCGH) on placental tissues for
molecular cytogenetic characterization of prenatally detected aneuploidy.
Case Report: A 30-year-old woman underwent amniocentesis at 18 weeks of gestation because of maternal anxiety. Results of amniocentesis
revealed a distal deletion of chromosome 3p. A malformed female fetus was delivered at 20 weeks of gestation with brachycephaly and facial
dysmorphisms, and a cytogenetic analysis of the cord blood revealed a karyotype of 46,XX,del(3)(p26.1),inv(9)(p12q13). A whole-genome
aCGH on uncultured cord blood and placental tissue was performed. The aCGH on cord blood revealed a 7.4-Mb deletion at 3p26.3-p26.1.
However, the aCGH on placental tissue revealed a 32.42-Mb gene dosage increase at 3p26.1-p22.1 and a 26.28-Mb gene dosage increase at
1p36.33-p36.11 in addition to a 7.4-Mb deletion at 3p26.3-p26.1, indicating confined placental mosaicism for partial trisomy 3p
(3p26.1/p22.1) and mosaicism for partial trisomy 1p (1p36.33/p36.11). The 7.4-Mb deleted region of 3p26.3-p26.1 contained the following
genes: CHL1, CNTN4, CRBN, LRRN1, and ITPR1.
Conclusion: Fetal tissue and amniocytes offer more reliable resources for aCGH characterization of prenatally detected aneuploidy compared
with placental tissues. A molecular cytogenetic evaluation of prenatally detected aneuploidy using placental tissue should raise concerns of
confined placental mosaicism and fetoplacental chromosomal discrepancy.
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Confined placental mosaicism is defined as a fetoplacental
cytogenetic discrepancy with chromosomal aberrations in the
placenta, which is absent from the fetal tissues [1]. The
occurrence rate of confined placental mosaicism by chorionic
villus sampling has been estimated to be 1e2% [2,3]. Recent
studies have shown that comparative genomic hybridization
(CGH) and array CGH (aCGH) are the most effective
molecular cytogenetic methods for investigating confinedFig. 1. Craniofacial appearan
Fig. 2. A karyotype of 46,XX,deplacental mosaicism at multiple sites in postdelivery placentas
[4e9]. Confined placental mosaicism may be associated with
intrauterine growth restriction (IUGR) [10], congenital
anomalies [11,12], and false-positive fetal aneuploidy scre
ening by maternal plasma DNA sequencing at noninvasive
prenatal diagnosis [13,14].
Here, we present our experience of prenatal diagnosis of a
distal 3p deletion associated with fetoplacental chromosomal
discrepancy and confined placental mosaicism detected by
aCGH.ce of the fetus at birth.
l(3)(p26.1),inv(9)(p12q13).
Fig. 3. Whole-genome array comparative genomic hybridization on cord blood shows a 7.4-Mb deletion at 3p26.3-p26.1 [arr 3p26.3p26.1 (1e7,496,015)  1]
(NCBI build 37).
280 C.-P. Chen et al. / Taiwanese Journal of Obstetrics & Gynecology 52 (2013) 278e284
Fig. 4. Whole-genome array comparative genomic hybridization on placenta shows a 7.4-Mb deletion at 3p26.3-p26.1 [arr 3p26.3p26.1 (1e7,496,015)  1], a
32.42-Mb gene dosage increase at 3p26.1-p22.1 [arr 3p26.1p22.1 (7,520,750e39,943,374)  2.64], and a 26.28-Mb gene dosage increase at 1p36.33-p36.11 [arr
1p36.33p36.11 (762,766e27,046,999)  2.55] (NCBI build 37), indicating mosaicism for partial trisomy 3p (3p26.1/p22.1) and 1p (1p36.33/p36.11) in the
placenta in addition to constitutional partial monosomy 3p (3p26.3/p26.1).
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A 30-year-old, gravida 2, para 1, woman underwent
amniocentesis at 18 weeks of gestation because of maternal
anxiety. She had experienced preterm labor with neonatal
death. Amniocentesis during this pregnancy revealed a distal
deletion of chromosome 3p. Prenatal ultrasound findings were
unremarkable. Premature rupture of the membranes occurred
at 20 weeks of gestation, and a 295-g malformed female fetus
was delivered with brachycephaly, hypertelorism, a flat nose,
micrognathia, low-set ears, and neonatal death occurred
(Fig. 1). A cytogenetic analysis of the cord blood revealed a
karyotype of 46,XX,del(3)(p26.1),inv(9)(p12q13) (Fig. 2).
The maternal karyotype was 46,XX,inv(9)(p12q13). The
paternal karyotype was 46,XY. Whole-genome aCGH on un-
cultured cord blood and placental tissue was performed using
NimbleGen ISCA Plus Cytogenetics Array (Roche Nim-
bleGen, Madison, WI, USA). An aCGH analysis on cord
blood revealed a 7.4-Mb deletion at 3p26.3-p26.1 [arr
3p26.3p26.1 (1e7,496,015)  1] (NCBI build 37) (Fig. 3).
The 7.4-Mb deleted region of 3p26.3-p26.1 contains theFig. 5. A cultured chorionic villi cell with a derivative chromosomefollowing genes: CHL1, CNTN4, CRBN, LRRN1, and ITPR1
(Fig. 3). However, an aCGH analysis on placental tissue
revealed a 32.42-Mb gene dosage increase at 3p26.1-p22.1 [arr
3p26.1p22.1 (7,520,750e39,943,374)  2.64] (NCBI build
37) and a 26.28-Mb gene dosage increase at 1p36.33-p36.11
[arr 1p36.33p36.11 (762,766e27,046,999)  2.55] in addition
to a 7.4-Mb deletion at 3p26.3-p26.1 [arr 3p26.3p26.1
(1e7,496,015)  1] (Fig. 4), indicating a mosaicism for partial
trisomy 3p (3p26.1/p22.1) and 1p (1p36.33/p36.11) in the
placenta in addition to a constitutional partial monosomy 3p
(3p26.3/p26.1). Mosaicism of a derivative chromosome 3
carrying partial 1p duplication and partial 3p deletion was
noted in 28% (7/25 cells) of the cultured chorionic villi cells
(Fig. 5).
Discussion
The 3p deletion syndrome [Online Mendelian Inheritance in
Man (OMIM) ID 613792] is a contiguous gene syndrome
associated with del(3)(p25/pter) and the phenotype of mental
retardation, IUGR, developmental delay, and craniofacial3 [der(3)] carrying partial 1p duplication and partial 3p deletion.
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triangular face, hypertelorism, palpebral ptosis, hypertrichosis,
synophrys, short and thick nose, long philtrum, micrognathia,
and low-set ears; and variable abnormalities of optic atrophy,
hypoplastic clavicles, pectus excavatum, scoliosis, polydactyly,
syndactyly, congenital heart defects, hiatal hernia, polycystic
renal dysplasia, and hypogenitalia [15e21].
The present case had haploinsufficiency of several impor-
tant genes responsible for the 3p deletion syndrome such as
CHL1 (OMIM ID: 607416), CNTN4 (OMIM ID: 607280),
CRBN (OMIM ID: 609262), and LRRN1 and ITPR1 (OMIM
ID: 147265). Pohjola et al [22] suggested that hap-
loinsufficiency of CHL1 may cause mild mental retardation,
learning difficulty, and IUGR but not profound mental retar-
dation and dysmorphisms. Cuoco et al [23] suggested that
CHL1 is a candidate gene for nonspecific mental retardation. It
was suggested that haploinsufficiency of CNTN4 and CRBN is
sufficient to cause mental retardation in the 3p deletion syn-
drome [23,24]. Fernandez et al [25,26] suggested that hap-
loinsufficiency of CNTN4 is associated with developmental
delay, growth retardation, and dysmorphisms in the 3p dele-
tion syndrome. LRRN1 is related to formation of the mid-
brainehindbrain boundary during neuronal development and
may be associated with mental disturbance in the 3p deletion
syndrome [19,27,28]. Cargile et al [29] suggested that ITPR1
is a candidate gene for mental retardation in the 3p deletion
syndrome.
The peculiar aspect of this presentation is the chromosomal
discrepancy between the fetus and placenta. In the present
case, confined placental mosaicism for 3p duplication and 1p
duplication was incidentally identified by aCGH on placental
tissues. Fetoplacental chromosomal discrepancy remains a
concern for a potential difference between the chorionic villus
sampling and the fetal and amniocyte karyotyping [12]. The
present case used direct uncultured chorionic villi cells for
aCGH analysis. Filges et al [8] further found that confined
placental mosaicism may cause misinterpretations of aCGH
analysis on direct chorionic villi cells due to chromosomal
discrepancy between cytotrophoblasts and mesenchymal villus
core. Conventional cytogenetics for culturing chorionic villi
cells requires additional chopping and enzymatic digestion,
and therefore allows the assessment of both cytotrophoblast
tissue and mesenchymal tissue; by contrast, the major pro-
portion of the extracted DNA from direct uncultured chorionic
villi cells used for aCGH analysis may originate from the
cytotrophoblasts only [8,30]. Chen et al [17] previously re-
ported fetoplacental discrepancy in prenatally detected mosaic
deletioneduplication syndrome of chromosome 3 and sug-
gested a limitation of using placenta as a diagnostic tool for
prenatal diagnosis of mosaic chromosome rearrangements.
Our case reinforces the notion that fetal tissue and amniocytes
offer more reliable resources for aCGH characterization of
prenatally detected aneuploidy compared with placental tis-
sues. Therefore, a molecular cytogenetic evaluation of prena-
tally detected aneuploidy using placental tissue should raise
concerns of confined placental mosaicism and fetoplacental
chromosomal discrepancy.Acknowledgments
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